InterWest Venture Management’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $9.92M | Hold |
1,614,911
| – | – | 48.05% | 1 |
|
2023
Q2 | $10.1M | Hold |
1,614,911
| – | – | 41.23% | 1 |
|
2023
Q1 | $7.7M | Hold |
1,614,911
| – | – | 37.02% | 2 |
|
2022
Q4 | $14M | Hold |
1,614,911
| – | – | 67.54% | 1 |
|
2022
Q3 | $19.2M | Hold |
1,614,911
| – | – | 59.24% | 1 |
|
2022
Q2 | $23M | Sell |
1,614,911
-1,620,000
| -50% | -$23.1M | 42.78% | 1 |
|
2022
Q1 | $67.4M | Hold |
3,234,911
| – | – | 25.73% | 2 |
|
2021
Q4 | $74.7M | Sell |
3,234,911
-635,000
| -16% | -$14.7M | 44.17% | 1 |
|
2021
Q3 | $115M | Sell |
3,869,911
-1,100,000
| -22% | -$32.8M | 47.76% | 1 |
|
2021
Q2 | $170M | Sell |
4,969,911
-500,000
| -9% | -$17.1M | 53.57% | 1 |
|
2021
Q1 | $180M | Sell |
5,469,911
-1,000,000
| -15% | -$32.9M | 47.32% | 1 |
|
2020
Q4 | $398M | Hold |
6,469,911
| – | – | 49.71% | 1 |
|
2020
Q3 | $230M | Buy |
+6,469,911
| New | +$230M | 66.28% | 1 |
|